Previous Vitamin D Supplementation and Morbidity and Mortality Outcomes in People Hospitalised for COVID19: A Cross-Sectional Study
Juan Antonio Arroyo-Díaz, Josep Julve, Bogdan Vlacho, Rosa Corcoy, Paola Ponte, Eva Román, Elena Navas-Méndez, Gemma Llauradó, Josep Franch-Nadal, Pere Domingo, Didac Mauricio
Frontiers in Public Health, doi:10.3389/fpubh.2021.758347
Aim: The study aim was to assess the association of vitamin D supplementation before hospital admission and severe outcomes in subjects admitted for COVID-19. Methods: We performed a cross-sectional analysis of pseudonymised medical record data from subjects admitted to the Hospital de la Santa Creu i Sant Pau (Barcelona, Spain) for COVID-19 during March and April 2020. The composite primary study outcome was defined as death and/or invasive mechanical ventilation (IMV). Association between risk factors and study outcomes was evaluated by bivariate analysis, followed by logistic regression analysis. Results: In total, 1,267 persons were hospitalised during the observation period. Overall, 14.9% of the subjects were on active vitamin D supplementation treatment before admission. The subjects in the vitamin D group were significantly older than subjects without vitamin D supplementation. We observed higher rates of the primary outcome (death and/or IMV) among the persons with previous use of vitamin D (30.1 vs. 22.9% in those not receiving treatment). In the bivariate analysis, previous use of vitamin D was positively associated with death and/or IMV [odds ratio (OR): 1.45 95% CI: 1.03; 2.04]; however, after adjustment for other risk factors this association disappeared (OR: 1.09 95%CI: 0.65; 1.81). Arroyo-Díaz et al. Vitamin D Supplementation and Severity of COVID19 Conclusion: We did not find an association between vitamin D supplementation before hospital admission and death and/or IMV in subjects admitted for COVID-19. The age and the burden of age-associated comorbidities were independently associated with the in-hospital events.
DATA AVAILABILITY STATEMENT The data analysed in this study is subject to the following licences/restrictions: The data controller for Hospital de la Santa Creu i Sant Pau does not allow the sharing of raw data. Requests to access these datasets should be directed to Pere Domingo, firstname.lastname@example.org.
ETHICS STATEMENT The studies involving human participants were reviewed and approved by the Ethics Committee of the Hospital de la Santa Creu i Sant Pau (Re. Nr. HSCSP-20/117). Written informed consent for participation was not required for this study in accordance with the national legislation and the institutional requirements.
AUTHOR CONTRIBUTIONS JA-D, JJ, JF-N, PD, and DM: conceptualisation. EN-M: formal analysis. JA-D, DM, PD, ER, and PP: resources and data curation. BV: writing-original draught preparation. BV, RC, JA-D, GL, JF-N, PD, and DM: writing-review and editing. DM and JF-N: supervision. JA-D: project administration. All authors contributed to the article and approved the submitted version.
SUPPLEMENTARY MATERIAL The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fpubh. 2021.758347/full#supplementary-material Conflict of Interest: RC has received advisory and/or speaking fees from Abbott, Ascensia, Lilly, MSD, Novo and Sanofi. JF-N has received advisory and or speaking fees from Astra-Zeneca, Ascensia, Boehringer Ingelheim, GSK, Lilly, MSD, Novartis, Novo Nordisk, and Sanofi; they received..
Annweiler, Corvaisier, Gautier, Dubée, Legrand et al., Vitamin d supplementation associated to better survival in hospitalised frail elderly covid-19 subjects: the geria-covid quasi-experimental study, Nutrients, doi:10.3390/nu12113377
Annweiler, Hanotte, De L'eprevier, Sabatier, Lafaie et al., Vitamin D and survival in COVID-19 subjects: a quasiexperimental study, J Steroid Biochem Mol Biol, doi:10.1016/j.jsbmb.2020.105771
Bassatne, Basbous, Chakhtoura, El Zein, Rahme et al., The link between COVID-19 and VItamin D (VIVID): a systematic review and meta-analysis, Metabolism, doi:10.1016/j.metabol.2021.154753
Caballero, Guide to Nutritional Supplements
Casado, Quesada, Naves, Peris, Jódar et al., Recomendaciones de la SEIOMM en la prevención y tratamiento del déficit de vitamina D, Rev Osteoporos Metab Min, doi:10.4321/S1889-836X2021000200007
Castillo, Costa, Barrios, Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among subjects hospitalised for COVID-19: a pilot randomised clinical study, J Steroid Biochem Mol Biol, doi:10.1016/j.jsbmb.2020.105751
Cozier, Castro-Webb, Hochberg, Rosenberg, Palmer, Lower serum 25(OH)D levels associated with higher risk of COVID-19 infection in US Black women, PLoS ONE, doi:10.1371/journal.pone.0255132
Crafa, Cannarella, Condorelli, Mongioì, Barbagallo et al., Influence of 25-hydroxy-cholecalciferol levels on SARS-CoV-2 infection and COVID-19 severity: a systematic review and metaanalysis, EClinicalMedicine, doi:10.1016/j.eclinm.2021.100967
Dana, Bannay, Bourst, Ziegler, Losser et al., Obesity and mortality in critically ill COVID-19 patients with respiratory failure, Int J Obes, doi:10.1038/s41366-021-00872-9
Dramé, Cofais, Hentzien, Proye, Coulibaly et al., Relation between vitamin D and covid-19 in aged people: a systematic review, Nutrients, doi:10.3390/nu13041339
González-Molero, Morcillo, Valdés, Pérez-Valero, Botas et al., Vitamin D deficiency in Spain: a population-based cohort study, Eur J Clin Nutr, doi:10.1038/ejcn.2010.265
Grove, Osokogu, Al-Khudairy, Mehrabian, Zanganeh et al., Association between vitamin D supplementation or serum vitamin D level and susceptibility to SARS-CoV-2 infection or COVID-19 including clinical course, morbidity and mortality outcomes? A systematic review, BMJ Open, doi:10.1136/bmjopen-2020-043737
Gu, Wang, Chen, Lu, Liu et al., PaO 2 /FiO 2 and IL-6 are risk factors of mortality for intensive care COVID-19 subjects, Sci Rep, doi:10.1038/s41598-021-86676-3
Hernández, Nan, Fernandez-Ayala, García-Unzueta, Hernández-Hernández et al., Vitamin D status in hospitalized subjects with SARS-CoV-2 infection, J Clin Endocrinol Metab, doi:10.1210/clinem/dgaa733
Ingham, Jones, Camargo, Kirman, Dowell et al., Association of vitamin D deficiency with severity of acute respiratory infection: A CASE-control study in New Zealand children, Eur Respir J
Karahan, Katkat, Impact of serum 25(OH) vitamin D level on mortality in patients with COVID-19 in Turkey, J Nutr Health Aging, doi:10.1007/s12603-020-1479-0
Kaufman, Niles, Kroll, Bi, Holick, SARS-CoV-2 positivity rates associated with circulating 25-hydroxyvitamin D levels, PLoS ONE, doi:10.1371/journal.pone.0239252
Kazemi, Mohammadi, Aghababaee, Golzarand, Clark et al., Association of vitamin D status with SARS-CoV-2 infection or COVID-19 severity: a systematic review and meta-analysis, Adv Nutr, doi:10.1093/advances/nmab012
Liu, Mao, Liang, Yang, Lu et al., Association between age and clinical characteristics and outcomes of COVID-19, Eur Respir J, doi:10.1183/13993003.01112-2020
Macaya, Paeres, Valls, Fernández-Ortiz, Del Castillo et al., Interaction between age and vitamin D deficiency in severe COVID-19 infection, Nutr Hosp, doi:10.20960/nh.03193
Mahase, Covid-19: death rate is 0.66% and increases with age, study estimates, BMJ, doi:10.1136/bmj.m1327
Meltzer, Best, Zhang, Vokes, Arora et al., Association of vitamin D levels, race/ethnicity, and clinical characteristics with COVID-19 test results, JAMA Netw Open, doi:10.1001/jamanetworkopen.2021.4117
Meltzer, Best, Zhang, Vokes, Arora et al., Association of vitamin D status and other clinical characteristics with COVID-19 test results, JAMA Netw Open, doi:10.1001/jamanetworkopen.2020.19722
Murai, Fernandes, Sales, Pinto, Goessler et al., Effect of vitamin D3 supplementation vs placebo on hospital length of stay in patients with severe COVID-19: a multicenter, double-blind, randomized controlled trial, doi:10.1101/2020.11.16.20232397
Oscanoa, Amado, Vidal, Laird, Ghashut et al., The relationship between the severity and mortality of SARS-COV-2 infection and 25-hydroxy vitamin D concentration -a meta-analysis, Adv Respir Med, doi:10.5603/ARM.a2021.0037
Petrelli, Luciani, Perego, Dognini, Colombelli et al., Therapeutic and prognostic role of vitamin D for COVID-19 infection: a systematic review and meta-analysis of 43 observational studies, J Steroid Biochem Mol Biol, doi:10.1016/j.jsbmb.2021.105883
Radujkovic, Hippchen, Tiwari-Heckler, Dreher, Boxberger, Vitamin D deficiency and outcome of COVID-19 subjects, Nutrients, doi:10.3390/nu12092757
Recovery Collaborative Group, Horby, Lim, Emberson, Mafham et al., Dexamethasone in Hospitalized Patients with Covid-19, N Engl J Med, doi:10.1056/NEJMoa2021436
Sabetta, Depetrillo, Cipriani, Smardin, Burns et al., Serum 25-hydroxyvitamin d and the incidence of acute viral respiratory tract infections in healthy adults, PLoS ONE, doi:10.1371/journal.pone.0011088
Spiro, Buttriss, Vitamin D: an overview of vitamin D status and intake in Europe, Nutr Bull, doi:10.1111/nbu.12108
Stroehlein, Wallqvist, Iannizzi, Mikolajewska, Metzendorf et al., Vitamin D supplementation for the treatment of COVID-19: a living systematic review, Cochrane Database. Syst Rev, doi:10.1002/14651858.CD015043
Verity, Okell, Dorigatti, Winskill, Whittaker et al., Estimates of the severity of coronavirus disease 2019: a model-based analysis, Lancet Infect Dis, doi:10.1016/S1473-3099(20)30243-7